There appeared to be fewer people on the show floor than last year, a view supported by companies we spoke to, but despite this there were many positives.
A varied roundtable and speaker programme is underway and this has already provided a platform for thought provoking presentations. In particular a plenary session on counterfeiting tackled the problems facing devices, active pharmaceutical ingredients and finish products.
in-PharmaTechnologist and Outsourcing-Pharma will bring you in-depth coverage of these issues in the coming days.